Advising Chaterhouse in the framework of the LBO of Novétude Santé.
Advising Chaterhouse in the framework of the LBO of Novétude Santé. With a turnover of 37 M€ in 2019, the private higher education group dedicated…
Advising Ciclad in the context of the acquisition of a majority stake in the Tibbloc Group
Advising Ciclad in the context of its acquisition of a majority stake in the Tibbloc Group specialized in the rental of complete and autonomous solutions…
Advising Sofilab Group 5 and investors in the context of the exit of Siparex
Advising Sofilab 5 Group and investors (new and existing) - Irpac Développement and UI Gestion, Nord Est Expansion in connection with the exit of Siparex and…
Advising Ciclad in connection with its acquisition of a stake in the Seri Group
Advising Ciclad in connection with its acquisition of a stake in the Seri Group specializing in street furniture. Advisers : Thomas Hermetet and Aurélie Bonsch,…
Advising the founder of Atelier du Sourcil
Advising the founder in the context of the sale and contribution of his shareholding in the Atelier du Sourcil group which, in 10 years, has…
Nada Sbaï and Thomas Hermetet named among the Best Lawyers 2020
Nada Sbaï for Mergers & Acquisitions and Thomas Hermetet for Corporate Law, are referenced in the new selection of Best Lawyers
Advising SystemX for the acquisition of Penaranda Informatique
Advising SystemX, a French company, publisher of software solutions for medical imaging, solutions for printing, engraving, interpretation, archiving of medical images in the context of…
Advising Alliance Entreprendre and Bpifrance in the LBO of Acial
We advised Alliance Entreprendre and Bpifrance in the LBO of Acial. Acial, a Parisian company specialized in software testing, begins its external growth by bringing…
Advising Biomega in the sale to Bioclinic
Advising Biomega (biomedical laboratories) in the sale of their shares to Bioclinic alongside Idia, Amundi PEF, Socadif Investissement and Actomezz. Advisors: Thomas Hermetet, Marina Llobell